kez.biosolutions GmbH
kez.biosolutions develops novel polyketide drug candidates through a proprietary bioreactor platform. Their kezbio-platform enables position-specific modifications of polyketide scaffolds to expand chemical diversity. The tech integrates organic chemistry, molecular biology, fermentation, genome editing, bioinformatics, and machine learning to design and produce candidates. They offer solutions to academic research and pharmaceutical companies via SaaS, licensing, and services, delivering custom derivatives and libraries. With a focus on antibiotics and sustainable production, they target scalable drug discovery and material-building blocks.
kez.biosolutions GmbH
kez.biosolutions develops novel polyketide drug candidates through a proprietary bioreactor platform. Their kezbio-platform enables position-specific modifications of polyketide scaffolds to expand chemical diversity. The tech integrates organic chemistry, molecular biology, fermentation, genome editing, bioinformatics, and machine learning to design and produce candidates. They offer solutions to academic research and pharmaceutical companies via SaaS, licensing, and services, delivering custom derivatives and libraries. With a focus on antibiotics and sustainable production, they target scalable drug discovery and material-building blocks.